CycloSPORINE Capsules — Class II drug recall D-0490-2017
Terminated recall by Amerisource Health Services, reported 2017-03-08, distributed nationwide. Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and
| Recall number | D-0490-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services, Columbus, OH, United States |
| Recall initiated | 2017-02-08 |
| Classified | 2017-02-24 |
| Reported by FDA | 2017-03-08 |
| Terminated | 2017-10-17 |
| Distributed | Nationwide (US) |
| Quantity | 454 cartons |
| Reason classes | specification failure |
| NDC | 68084-0879, 68084-0879-25, 68084-0879-95, 68084-0921, 68084-0921-25, 68084-0921-95 |
| Lot numbers | 154527 |
| Expiration dates | 2017-04-30 |
Product
CycloSPORINE Capsules, USP, 100 mg, 30 count (5x6) blister cartons, Rx only, Distributed by American Health Packaging, Columbus, OH--- NDC 68084-921-25
Reason for recall
Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0490-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.